Standard

Comparative study on application of 177Lu-labeled rituximab, tetulomab, cetuximab and huA33 monoclonal antibodies to targeted radionuclide therapy. / Zakaly, Hesham M.H.; Mostafa, Mostafa Y.A.; Dzholumbetov, Sergey et al.
In: Biomedical Physics and Engineering Express, Vol. 7, No. 1, 015015, 11.2020.

Research output: Contribution to journal › Article › peer-review

Harvard

Zakaly, HMH, Mostafa, MYA, Dzholumbetov, S, Issa, SAM, Tekin, HO, Erdemir, RU & Zhukovsky, M 2020, 'Comparative study on application of 177Lu-labeled rituximab, tetulomab, cetuximab and huA33 monoclonal antibodies to targeted radionuclide therapy', Biomedical Physics and Engineering Express, vol. 7, no. 1, 015015. https://doi.org/10.1088/2057-1976/abd307

APA

Zakaly, H. M. H., Mostafa, M. Y. A., Dzholumbetov, S., Issa, S. A. M., Tekin, H. O., Erdemir, R. U., & Zhukovsky, M. (2020). Comparative study on application of 177Lu-labeled rituximab, tetulomab, cetuximab and huA33 monoclonal antibodies to targeted radionuclide therapy. Biomedical Physics and Engineering Express, 7(1), [015015]. https://doi.org/10.1088/2057-1976/abd307

Vancouver

Zakaly HMH, Mostafa MYA, Dzholumbetov S, Issa SAM, Tekin HO, Erdemir RU et al. Comparative study on application of 177Lu-labeled rituximab, tetulomab, cetuximab and huA33 monoclonal antibodies to targeted radionuclide therapy. Biomedical Physics and Engineering Express. 2020 Nov;7(1):015015. doi: 10.1088/2057-1976/abd307

Author

Zakaly, Hesham M.H. ; Mostafa, Mostafa Y.A. ; Dzholumbetov, Sergey et al. / Comparative study on application of 177Lu-labeled rituximab, tetulomab, cetuximab and huA33 monoclonal antibodies to targeted radionuclide therapy. In: Biomedical Physics and Engineering Express. 2020 ; Vol. 7, No. 1.

BibTeX

@article{dae149d026d042078e7e4b0905641ecf,
title = "Comparative study on application of 177Lu-labeled rituximab, tetulomab, cetuximab and huA33 monoclonal antibodies to targeted radionuclide therapy",
keywords = "BIODISTRIBUTION, NEUROENDOCRINE TUMORS, cetuximab, huA33, lutetium-177, monoclonal antibody, rituximab, targeted radionuclide therapy, tetulomab",
author = "Zakaly, {Hesham M.H.} and Mostafa, {Mostafa Y.A.} and Sergey Dzholumbetov and Issa, {Shams A.M.} and Tekin, {H. O.} and Erdemir, {R. Uslu} and M. Zhukovsky",
year = "2020",
month = nov,
doi = "10.1088/2057-1976/abd307",
language = "English",
volume = "7",
journal = "Biomedical Physics and Engineering Express",
issn = "2057-1976",
publisher = "Institute of Physics Publishing (IOP)",
number = "1",

}

RIS

TY - JOUR

T1 - Comparative study on application of 177Lu-labeled rituximab, tetulomab, cetuximab and huA33 monoclonal antibodies to targeted radionuclide therapy

AU - Zakaly, Hesham M.H.

AU - Mostafa, Mostafa Y.A.

AU - Dzholumbetov, Sergey

AU - Issa, Shams A.M.

AU - Tekin, H. O.

AU - Erdemir, R. Uslu

AU - Zhukovsky, M.

PY - 2020/11

Y1 - 2020/11

KW - BIODISTRIBUTION

KW - NEUROENDOCRINE TUMORS

KW - cetuximab

KW - huA33

KW - lutetium-177

KW - monoclonal antibody

KW - rituximab

KW - targeted radionuclide therapy

KW - tetulomab

UR - http://www.scopus.com/inward/record.url?scp=85098270596&partnerID=8YFLogxK

UR - https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=tsmetrics&SrcApp=tsm_test&DestApp=WOS_CPL&DestLinkType=FullRecord&KeyUT=000600804600001

U2 - 10.1088/2057-1976/abd307

DO - 10.1088/2057-1976/abd307

M3 - Article

AN - SCOPUS:85098270596

VL - 7

JO - Biomedical Physics and Engineering Express

JF - Biomedical Physics and Engineering Express

SN - 2057-1976

IS - 1

M1 - 015015

ER -

ID: 20406920